+1 (630) 270-2921 info@fdahelp.us

FDA Drug Label Review Services

Label review is a critical regulatory process that ensures drug labeling complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act). Accurate labeling is essential for patient safety, market access, and protecting your company from enforcement actions.
FD&C Act Compliance OTC Monograph Review Drug Facts Panel Since 2009
fda corrected drug label
FD&C Act · 21 CFR 201
LMG reviews your drug label against all applicable FDA requirements and delivers a corrected, ready-to-use compliant version.
FD&C ActCompliance
OTCMonograph Review
7–10 daysTurnaround
$649/ DrugLMG Fee

About FDA Drug Label Review

Drug labels serve as the primary source of information for healthcare professionals and consumers, making accuracy, clarity, and compliance essential for patient safety and regulatory approval. A compliant label not only supports regulatory approval and market access but also protects companies from warning letters, import alerts, recalls, detentions, and enforcement actions.

Labeling is also one of the first things FDA looks at. Because a label can be examined without opening a shipment, testing a sample, or inspecting a facility, it is frequently the trigger for an import refusal or an enforcement action — even when the product itself is manufactured to a high standard. Under Section 502 of the Federal Food, Drug, and Cosmetic Act, a drug is considered misbranded if its labeling is false or misleading, omits required information, or fails to present that information with the required prominence. Misbranding alone is enough to keep a product out of U.S. commerce.

The FDA issues an average of 700–800 warning letters each year, most of which are due to label non-compliance. You can avoid this by opting for our Label Review Service, designed to help prevent potential detention and delays caused by label non-compliance.

At Liberty Management Group Ltd. our experts review your label, identify compliance gaps, and provide a revised, ready-to-use FDA-compliant version—accurately, efficiently, and cost-effectively.

Our regulatory experts support you in the following areas:

  • Identification of monograph
  • Dosage Form and Strength
  • Drug Facts panel requirements
  • Marketing taglines and claims
  • Overall Formatting and Presentation

 

What our review covers

Our review identifies formatting deficiencies, missing or incorrect regulatory statements, inconsistencies, and potential risks that could result in regulatory observations or FDA warning letters. Each review includes detailed comments, recommendations, and actionable revisions to help manufacturers efficiently understand the deficiencies.

We also check for the issues that most often cause avoidable problems at the port and in the market: inactive ingredients listed out of order or incompletely, warnings that have been paraphrased instead of stated as required, missing “Keep out of reach of children” or poison-control language, absent tamper-evident statements where they are required, inconsistent labeler codes and NDC formats, and text that is technically present but too small or too low in contrast to be legible.

fda drug label review

FDA Drug Label Review — Frequently Asked Questions

Common questions about FDA drug labeling compliance.
OTC monograph drug labels must comply with the applicable OTC monographs and 21 CFR regulations.
FDA approves labeling as part of the NDA/ANDA process. For OTC drugs under an approved monograph, the FDA does not pre-approve the label prior to marketing; the manufacturer is responsible for compliance.
Yes, provided they are consistent with the monograph and do not misbrand the product.
A compliant drug label may contain the below information (this is not a complete list):
  • Drug name (established name and pharmacological category)
  • Dosage form and strength
  • Indications and usage
  • Directions for use and Warnings
  • Inactive ingredients
  • Proper Drug Facts formatting and layout
 
Yes. All drugs marketed in the U.S. must meet the same FDA labeling standards regardless of where they are manufactured.
Yes. Requirements vary depending on whether the label is in English only or is bilingual.
Non-compliant products may be deemed misbranded, leading to FDA warning letters, import alerts, detentions, or recalls.

Need Your Drug Label?

Contact our regulatory experts via email or phone, or submit your details through our online form.

Submit Your Details Online Contact Us